These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35003069)

  • 1. Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma.
    Mao R; Yang F; Zhang T; Li J
    Front Immunol; 2021; 12():756282. PubMed ID: 35003069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
    Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
    Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granzyme family acts as a predict biomarker in cutaneous melanoma and indicates more benefit from anti-PD-1 immunotherapy.
    Wu X; Wang X; Zhao Y; Li K; Yu B; Zhang J
    Int J Med Sci; 2021; 18(7):1657-1669. PubMed ID: 33746582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring a specialized programmed-cell death patterns to predict the prognosis and sensitivity of immunotherapy in cutaneous melanoma via machine learning.
    Xiao L; He R; Hu K; Song G; Han S; Lin J; Chen Y; Zhang D; Wang W; Peng Y; Zhang J; Yu P
    Apoptosis; 2024 Aug; 29(7-8):1070-1089. PubMed ID: 38615305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic cell death signatures from on-treatment tumor specimens predict immune checkpoint therapy response in metastatic melanoma.
    Zeng H; Jiang Q; Zhang R; Zhuang Z; Wu J; Li Y; Fang Y
    Sci Rep; 2024 Oct; 14(1):22872. PubMed ID: 39358546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a prognostic model for skin melanoma based on the persistent tumor mutation burden and determining IL17REL as a therapeutic target.
    Xu M; Ma X; Wang Y; Yu Z; Zheng X; Dai H; Xue C
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):313. PubMed ID: 38900244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature.
    Yang Y; Long X; Li G; Yu X; Liu Y; Li K; Tian X
    Bioengineered; 2021 Dec; 12(1):1803-1812. PubMed ID: 34047683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma.
    Hu B; Wei Q; Zhou C; Ju M; Wang L; Chen L; Li Z; Wei M; He M; Zhao L
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107162. PubMed ID: 33168410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.
    Qu Y; Zhang S; Zhang Y; Feng X; Wang F
    Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
    Tian M; Yang J; Han J; He J; Liao W
    Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immune risk score with potential implications in prognosis and immunotherapy of metastatic melanoma.
    Sheng Y; Tong L; Geyu L
    Int Immunopharmacol; 2020 Nov; 88():106921. PubMed ID: 32871477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of Tumor Immunogenicity Based Gene Signature for Skin Cancer Risk Stratification.
    Yavartanoo M; Yi GS
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer.
    Mei J; Xing Y; Lv J; Gu D; Pan J; Zhang Y; Liu J
    Int Immunopharmacol; 2020 Nov; 88():106882. PubMed ID: 32799114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of the B Cell-Associated Fc Receptor-like Molecule-Based Prognostic Signature in Skin Cutaneous Melanoma.
    Liu Y; Chen Y; Hu X; Meng J; Li X
    Biomed Res Int; 2020; 2020():8509805. PubMed ID: 32908921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 9-Gene Signature Correlated With CD8
    Yan K; Lu Y; Yan Z; Wang Y
    Front Immunol; 2021; 12():622563. PubMed ID: 34220795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor fitness, immune exhaustion and clinical outcomes: impact of immune checkpoint inhibitors.
    Bubie A; Gonzalez-Kozlova E; Akers N; Villanueva A; Losic B
    Sci Rep; 2020 Mar; 10(1):5062. PubMed ID: 32193450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Signature of 23 Immunity-Related Gene Pairs Is Prognostic of Cutaneous Melanoma.
    Xue YN; Xue YN; Wang ZC; Mo YZ; Wang PY; Tan WQ
    Front Immunol; 2020; 11():576914. PubMed ID: 33193373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8
    Wang Z; Peng M
    Sci Rep; 2021 Apr; 11(1):9164. PubMed ID: 33911146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.